Masato Fukunaga

Masato Fukunaga

Auto-generated profile, based on publicly available information

Masato Fukunaga

Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Heart Rhythm
Verified
Journal Article
Open access
KHKentaro Hayashi
Kentaro Hayashi
YAYoshimori An
Yoshimori An
MNMichio Nagashima
Michio Nagashima
KHKenichi Hiroshima
Kenichi Hiroshima
MOMasatsugu Ohe
Masatsugu Ohe
MGMasahiko Goya
Masahiko Goya
Pulmonary vein (PV) isolation is an established treatment strategy for paroxysmal atrial fibrillation (PAF). However, the recurrence rate of PAF is 8% to 37%, despite repeated procedures, and the catheter ablation strategy for PAF with non-PV foci is unclear. The purpose of this study was to assess the PAF ablation strategy for non-PV foci. The study included 304 consecutive patients undergoing PAF ablation (209 males, age 63.0 ± 10.4 years) divided into 3 groups: group 1 (245 patients) with no inducible non-PV foci; group 2 (34 patients) with atrial fibrillation (AF) originating from non-PV foci and all the foci successfully ablated; and group 3 (25 patients) with AF originating from non-PV triggers, but without all foci being ablated or with persistently inducible AF. Mean follow-up period was 26.9 ± 11.8 months, and AF recurrence rates since the last procedure were 9.8%, 8.8%, and 68.0% in groups 1, 2, and 3, respectively. There was no statistically significant difference in recurrence rate between groups 1 and 2 (P = .89); however, there were statistically significant differences between groups 3 and 1 (P <.0001) and groups 3 and 2 (P <.0001). The patients in group 2 had an AF-free outcome to equivalent to those who had PV foci in group 1 (P = .83). Success rates can be improved for PAF ablation if non-PV foci are detected and eliminated.

6 February 2021 in ESC Heart Failure
Verified
Journal Article
Open access
PDF file
KKKenji Kanenawa
Kenji Kanenawa
AIAkihiro Isotani
Akihiro Isotani
KYKyohei Yamaji
Kyohei Yamaji
MNMiho Nakamura
Miho Nakamura
YTYuichi Tanaka
Yuichi Tanaka
KAKenji Ando
Kenji Ando
Aims There is currently no gold standard in evaluating frailty in patients with heart failure (HF), and the prognostic value of frailty according to the Canadian Study of Health and Aging Clinical Frailty Scale (CFS) on mortality in patients with HF is still unknown. Methods and results Among consecutive 596 patients after their discharge from HF in Kokura Memorial Hospital (Kitakyushu, Japan) during 2015, their frailty at discharge was assessed according to CFS. Patients were classified into three groups: low (N = 232, 38.9%), intermediate (N = 230, 38.6%), and high (N = 134, 22.5%). The primary endpoint was defined as 2 year all‐cause death. The mean age was 76.6 ± 10.1 years, and 55.3% were men in entire cohort. There were significant differences in age, living environment, and dementia among low, intermediate, and high CFS groups. Left ventricular ejection fraction (LVEF) and co‐morbidities such as severe renal failure and severe anaemia tended to increase with frailty severity, while body mass index (BMI) and albumin level tended to decrease with frailty severity. Two year cumulative incidences of all‐cause death for the three groups were 12.8%, 25.4%, and 52.7% (P < 0.001), respectively. This significant difference in the risk for all‐cause death among the CFS groups was driven by the risk for cardiac (8.6%, 14.2%, and 31.0%, respectively, P < 0.001) and non‐cardiac death (4.6%, 13.0%, and 31.4%, respectively, P < 0.001). The multivariate analysis showed that high frailty was independently associated with all‐cause death (intermediate CFS group: adjusted hazard ratio, 1.43, 95% confidence interval, 0.86–2.36, P = 0.16; high CFS group: adjusted hazard ratio, 3.90, 95% confidence interval, 2.32–6.55, P < 0.001), and this result was consistent, irrespective of stratification based on age, sex, BMI, and LVEF without significant interaction. Conclusions The simple CFS tool was successful in predicting the risk for all‐cause death in patients with HF, and frailty according to CFS was independently associated with all‐cause death irrespective of stratification based on age, sex, BMI, and LVEF without significant interaction. The CFS is a valuable prognostic tool in clinical settings.

1 May 2017 in JACC: Clinical Electrophysiology
Verified
Journal Article
Closed access
MSMarek Sramko
Marek Sramko
DWDan Wichterle
Dan Wichterle
VMVojtech Melenovsky
Vojtech Melenovsky
MCMarcell Clemens
Marcell Clemens
MFMasato Fukunaga
Masato Fukunaga
JKJosef Kautzner
Josef Kautzner

1 August 2020 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
JHJun Hirokami
Jun Hirokami
KHKenichi Hiroshima
Kenichi Hiroshima
KYKyohei Yamaji
Kyohei Yamaji
KKKengo Korai
Kengo Korai
MNMichio Nagashima
Michio Nagashima
MGMasahiko Goya
Masahiko Goya

26 July 2018 in Clinical Research in Cardiology
Verified
Journal Article
Closed access
PDF file
MSMarek Sramko
Marek Sramko
DWDan Wichterle
Dan Wichterle
VMVojtech Melenovsky
Vojtech Melenovsky
JFJanka Franekova
Janka Franekova
MCMarcell Clemens
Marcell Clemens
JKJosef Kautzner
Josef Kautzner

18 September 2022 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PSPredrag Stojadinovic
Predrag Stojadinovic
ADAslesha Deshraju
Aslesha Deshraju
DWDan Wichterle
Dan Wichterle
MFMasato Fukunaga
Masato Fukunaga
PPPetr Peichl
Petr Peichl
MŠMarek Šramko
Marek Šramko